Rheumatologic Symptoms in Patients with Mixed Cryoglobulinemia

  • Gianfranco Ferraccioli
  • Francesca Faustini
  • Elisa Gremese


Chronic hepatitis C virus (HCV) infection is frequent worldwide and causes hepatic damage as well as a wide spectrum of extrahepatic manifestations. This capacity of the infection to determine several extrahepatic comorbidities was demonstrated early after discovery of the infectious agent and appears to be related to its ability to infect immune cells, namely B cells. This can lead to their abnormal activation and end in an autoimmune or lymphoproliferative disease. The strict link between HCV and mixed cryoglobulinemia (MC) is well known. In addition, it is clear that many symptoms of rheumatologic interest can be present in the setting of chronic HCV infection, such as arthralgias and fatigue. In some cases, as in sicca syndrome, MC manifests as a true infectious-related autoimmune disease. Here we review the main rheumatic symptoms that can occur during MC (HCV chronic infection) and discuss the principles underlying their clinical management.


Interstitial Lung Disease Fibromyalgia Syndrome Mixed Cryoglobulinemia Sicca Syndrome Mixed Cryoglobulinemia Patient 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Trendelenburg M, Schifferli JA (1998) Cryoglobulins are not essential. Ann Rheum Dis 57:3–5PubMedCrossRefGoogle Scholar
  2. 2.
    Vassilopoulos D, Calabrese LH (2005) Extrahepatic immunological complications of HCV infection. AIDS 19(Suppl 3):S123–S127PubMedCrossRefGoogle Scholar
  3. 3.
    Ferri C, Sebastiani M, Giuggioli D et al (2004) Mixed cryoglobulinemia: demographic, clinical, and serological features, and survival in 231 patients. Semin Arthritis Rheum 33:355–374PubMedCrossRefGoogle Scholar
  4. 4.
    Sansonno D, Dammacco F (2005) Hepatitis C virus, cryoglobulinaemia, and vasculitis: immune complex relations. Lancet Infect Dis 5:227–236PubMedCrossRefGoogle Scholar
  5. 5.
    Antonelli A, Ferri C, Fallahi P et al (2008) High values of CXCL10 serum levels in mixed cryoglobulinemia associated with hepatitis C infection. Am J Gastroenterol 103:2488–2494PubMedCrossRefGoogle Scholar
  6. 6.
    Antonelli A, Ferri C, Fallahi P et al (2009) CXCL10 and CCL2 chemokine serum levels in patients with hepatitis C associated with autoimmune thyroiditis. J Interferon Cytokine Res 29:345–351PubMedCrossRefGoogle Scholar
  7. 7.
    Fabris M, Quartuccio L, Sacco S et al (2007) B-Lymphocyte stimulator (BLyS) up-regulation in mixed cryoglobulinaemia syndrome and hepatitis-C virus infection. Rheumatology (Oxford) 46:37–43CrossRefGoogle Scholar
  8. 8.
    Cacoub P, Poynard T, Ghillani P et al (1999) Extrahepatic manifestations of HCV. Arthritis Rheum 42:2204–2212PubMedCrossRefGoogle Scholar
  9. 9.
    Buskila D (2000) Hepatitis C-associated arthritis. Curr Opin Rheumatol 12:295–299PubMedCrossRefGoogle Scholar
  10. 10.
    Sène D, Ghillani-Dalbin P, Limal N et al (2006) Anti-cyclic citrullinated peptide antibodies in hepatitis C virus associated rheumatological manifestations and Sjogren’s syndrome. Ann Rheum Dis 65:394–397PubMedCrossRefGoogle Scholar
  11. 11.
    Liu FC, Chao YC, Hou TY et al (2008) Usefulness of anti-CCP antibodies in patients with hepatitis C virus infection with or without arthritis, rheumatoid factor, or cryoglobulinemia. Clin Rheumatol 27:463–467PubMedCrossRefGoogle Scholar
  12. 12.
    Wener MH, Hutchinson K, Morishima C et al (2004) Absence of antibodies to cyclic citrullinated peptide in sera of patients with hepatitis C virus infection and cryoglobulinemia. Arthritis Rheum 50:2305–2308PubMedCrossRefGoogle Scholar
  13. 13.
    Magy N, Cribier B, Schmitt C et al (1999) Effects of corticosteroids on HCV infection. Int J Immunopharmacol 21(4):253–261PubMedCrossRefGoogle Scholar
  14. 14.
    Nissen MJ, Fontanges E, Allam Y et al (2005) Rheumatological manifestations of hepatitis C: incidence in a rheumatology and non-rheumatology setting and the effect of methotrexate and interferon. Rheumatology 44:1016–1020PubMedCrossRefGoogle Scholar
  15. 15.
    Ferri C, Ferraccioli G, Ferrari D, GISEA Group et al (2008) Safety of anti-tumor necrosis factor-alpha therapy in patients with rheumatoid arthritis and chronic hepatitis C virus infection. J Rheumatol 35:1944–1949PubMedGoogle Scholar
  16. 16.
    Zaja F, De Vita S, Mazzaro C et al (2003) Efficacy and safety of rituximab in type II mixed cryoglobulinemia. Blood 101:3827–3834PubMedCrossRefGoogle Scholar
  17. 17.
    Galeazzi M, Bellisai F, Manganelli S et al (2006) Cyclosporine A for the treatment of autoimmune disorders in HCV infected patients. Autoimmun Rev 5:493–498PubMedCrossRefGoogle Scholar
  18. 18.
    Pirisi M, Scott C, Fabris C et al (1994) Mild sialoadenitis: a common finding in patients with hepatitis C virus infection. Scand J Gastroenterol 29:940–942PubMedCrossRefGoogle Scholar
  19. 19.
    Scott CA, Avellini C, Desinan L et al (1997) Chronic lymphocytic sialoadenitis in HCV-related chronic liver disease: comparison with Sjogren’s syndrome. Histopathology 30:41–48PubMedCrossRefGoogle Scholar
  20. 20.
    Koike K, Moriya K, Ishibashi K et al (1997) Sialadenitis histologically resembling Sjogren syndrome in mice transgenic for hepatitis C virus envelope genes. Proc Natl Acad Sci USA 94:233–236PubMedCrossRefGoogle Scholar
  21. 21.
    Toussirot E, Le Huédé G, Mougin C et al (2002) Presence of hepatitis C virus RNA in the salivary glands of patients with Sjögren’s syndrome and hepatitis C virus infection. J Rheumatol 29:2382–2385PubMedGoogle Scholar
  22. 22.
    Arrieta JJ, Rodríguez-Iñigo E, Ortiz-Movilla N et al (2001) In situ detection of hepatitis C virus RNA in salivary glands. Am J Pathol 158:259–264PubMedCrossRefGoogle Scholar
  23. 23.
    De Vita S, Damato R, De Marchi G et al (2002) True primary Sjögren’s syndrome in a subset of patients with hepatitis C infection: a model linking chronic infection to chronic sialadenitis. Isr Med Assoc J 4:1101–1105PubMedGoogle Scholar
  24. 24.
    Vitali C, Bombardieri S, Jonsson R, European Study Group on Classification Criteria for Sjögren’s Syndrome et al (2002) Classification criteria for Sjogren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61:554–558PubMedCrossRefGoogle Scholar
  25. 25.
    Ramos-Casals M, Loustaud-Ratti V, De Vita S, SS-HCV Study Group et al (2005) Sjögren syndrome associated with hepatitis C virus: a multicenter analysis of 137 cases. Medicine 84:81–89PubMedCrossRefGoogle Scholar
  26. 26.
    Buskila D, Shnaider A, Neumann L et al (1997) Fibromyalgia in hepatitis C virus infection. Another infectious disease relationship. Arch Intern Med 157:2497–2500PubMedCrossRefGoogle Scholar
  27. 27.
    Kozanoglu E, Canataroglu A, Abayli B et al (2003) Fibromyalgia syndrome in patients with hepatitis C infection. Rheumatol Int 23:248–251PubMedCrossRefGoogle Scholar
  28. 28.
    Rocco A, Gargano S, Provenzano A et al (2001) Incidence of autoimmune thyroiditis in interferon alpha treated and untreated patients with chronic hepatitis C virus infection. Neuro Endocrinol Lett 22:39–44PubMedGoogle Scholar
  29. 29.
    Gemignani F, Pavesi G, Fiocchi A et al (1992) Peripheral neuropathy in essential mixed cryoglobulinaemia. J Neurol Neurosurg Psychiatry 55:116–120PubMedCrossRefGoogle Scholar
  30. 30.
    Alpa M, Ferrero B, Cavallo R et al (2008) Antineuronal antibodies in patients with HCV related mixed cryoglobulinemia. Autoimmun Rev 8:56–58PubMedCrossRefGoogle Scholar
  31. 31.
    Ramos-Casals M, Cervera R, Lagrutta M, Hispanoamerican Study Group of Autoimmune Manifestations of Chronic Viral Disease (HISPAMEC) et al (2004) Clinical features related to antiphospholipid syndrome in patients with chronic viral infections (hepatitis C virus/HIV infection): description of 82 cases. Clin Infect Dis 38:1009–1016PubMedCrossRefGoogle Scholar
  32. 32.
    Sène D, Limal N, Cacoub P (2004) Hepatitis C virus-associated extrahepatic manifestations: a review. Metab Brain Dis 19:357–381PubMedCrossRefGoogle Scholar
  33. 33.
    Ferri C, Moriconi L, Gremignai G et al (1986) Treatment of the renal involvement in mixed cryoglobulinemia with prolonged plasma exchange. Nephron 43:246–253PubMedCrossRefGoogle Scholar
  34. 34.
    Madore F, Lazarus JM, Brady HR (1996) Therapeutic plasma exchange in renal diseases. J Am Soc Nephrol 7:367–386PubMedGoogle Scholar
  35. 35.
    Rossi D, Mansouri M, Baldovino S et al (2004) Nail fold videocapillaroscopy in mixed cryoglobulinemia. Nephrol Dial Transplant 19:2245–2249PubMedCrossRefGoogle Scholar
  36. 36.
    Inokuchi M, Ito T, Uchikoshi M et al (2009) Infection of B cells with hepatitis C virus for the development of ­lymphoproliferative disorders in patients with chronic ­hepatitis C. J Med Virol 81:619–627PubMedCrossRefGoogle Scholar
  37. 37.
    Silvestri F, Pipan C, Barillari G et al (1996) Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders. Blood 87:4296–4301PubMedGoogle Scholar
  38. 38.
    de Sanjose S, Benavente Y, Vajdic CM et al (2008) Hepatitis C and non-Hodgkin lymphoma among 4784 cases and 6269 controls from the International Lymphoma Epidemiology Consortium. Clin Gastroenterol Hepatol 6:451–458PubMedCrossRefGoogle Scholar
  39. 39.
    Charles ED, Green RM, Marukian S et al (2008) Clonal expansion of immunoglobulin M+CD27+ B cells in HCV-associated mixed cryoglobulinemia. Blood 111:1344–1356PubMedCrossRefGoogle Scholar
  40. 40.
    Zignego AL, Giannini C, Ferri C (2007) Hepatitis C virus-related lymphoproliferative disorders: an overview. World J Gastroenterol 13:2467–2478PubMedGoogle Scholar
  41. 41.
    De Vita S, Sacco C, Sansonno D et al (1997) Characterization of overt B-cell lymphomas in patients with hepatitis C virus infection. Blood 90:776–782PubMedGoogle Scholar
  42. 42.
    Ferri C, Caracciolo F, La Civita L et al (1994) Hepatitis C virus infection and B-cell lymphomas. Eur J Cancer 30A:1591–1592PubMedCrossRefGoogle Scholar
  43. 43.
    Ferri C, Monti M, La Civita L et al (1994) Hepatitis C virus infection in non-Hodgkin’s B-cell lymphoma complicating mixed cryoglobulinaemia. Eur J Clin Invest 24:781–784PubMedCrossRefGoogle Scholar
  44. 44.
    Zignego AL, Giannelli F, Marrocchi ME et al (2000) T (14;18) translocation in chronic hepatitis C virus infection. Hepatology 31:474–479PubMedCrossRefGoogle Scholar
  45. 45.
    Meliconi R, Andreone P, Fasano L et al (1996) Incidence of hepatitis C virus infection in Italian patients with idiopathic pulmonary fibrosis. Thorax 51(3):315–317PubMedCrossRefGoogle Scholar
  46. 46.
    Bombardieri S, Paoletti P, Ferri C et al (1979) Lung involvement in essential mixed cryoglobulinemia. Am J Med 66:748–756PubMedCrossRefGoogle Scholar
  47. 47.
    Bertorelli G, Pesci A, Manganelli P et al (1991) Subclinical pulmonary involvement in essential mixed cryoglobulinemia assessed by bronchoalveolar lavage. Chest 100:1478–1479PubMedCrossRefGoogle Scholar
  48. 48.
    Viegi G, Fornai E, Ferri C et al (2005) Lung function in essential mixed cryoglobulinemia: a short-term follow-up. Clin Rheumatol 8:331–338CrossRefGoogle Scholar
  49. 49.
    Manganelli P, Giuliani N, Fietta P et al (2005) OPG/RANKL system imbalance in a case of hepatitis C-associated osteosclerosis: the pathogenetic key? Clin Rheumatol 24:296–300PubMedCrossRefGoogle Scholar
  50. 50.
    Fiore CE, Riccobene S, Mangiafico R et al (2005) Hepatitis C associated osteosclerosis (HCAO): report of a new case with involvement of the OPG/RANKL system. Osteoporos Int 16:2180–2184PubMedCrossRefGoogle Scholar
  51. 51.
    Saadoun D, Resche-Rigon M, Thibault V et al (2006) Antiviral therapy for hepatitis C virus – associated mixed cryoglobulinemia vasculitis: a long-term follow-up study. Arthritis Rheum 54:3696–3706PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 2012

Authors and Affiliations

  • Gianfranco Ferraccioli
    • 1
  • Francesca Faustini
    • 2
  • Elisa Gremese
    • 1
  1. 1.Division of Rheumatology, Institute of Rheumatology and Affine Sciences (IRSA), School of MedicineCIC – Catholic University of the Sacred HeartRomeItaly
  2. 2.Division of Rheumatology, Institute of Rheumatology and Affine Sciences (IRSA)CIC – Catholic University of the Sacred HeartRomeItaly

Personalised recommendations